METHYLPREDNISOLONE FOR THE CONTROL OF CMF-INDUCED EMESIS

被引：32

作者：

CHIARA, S

CAMPORA, E

LIONETTO, R

BRUZZI, P

ROSSO, R

机构：

[1] IST NAZL RIC CANC, DEPT MED ONCOL, V BENEDETTO XV 10, I-16132 GENOVA, ITALY

[2] IST NAZL RIC CANC, CLIN EPIDEMIOL UNIT, I-16132 GENOVA, ITALY

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1987年 / 10卷 / 03期

关键词：

D O I：

10.1097/00000421-198706000-00021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：264 / 267

页数：4

共 16 条

[1] AAPRO MS, 1983, P AM SOC CLIN ONCO C, V364, P93
[2] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER
BONADONNA, G
BRUSAMOLINO, E
VALAGUSSA, P
ROSSI, A
BRUGNATELLI, L
BRAMBILLA, C
DELENA, M
TANCINI, G
BAJETTA, E
MUSUMECI, R
VERONESI, U
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) : 405 - 410
[3] DOSE-RESPONSE EFFECT OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
BONADONNA, G
VALAGUSSA, P
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) : 10 - 15
[4] BUI NB, 1982, CANCER TREAT REP, V66, P2107
[5] THE ANTIEMETIC EFFICACY OF METHYLPREDNISOLONE COMPARED WITH METOCLOPRAMIDE IN OUTPATIENTS RECEIVING ADJUVANT CMF CHEMOTHERAPY FOR BREAST-CANCER - A RANDOMIZED TRIAL
CAMPORA, E
CHIARA, S
BRUZZI, P
SCARSI, P
ROSSO, R
[J]. TUMORI JOURNAL, 1985, 71 (05): : 459 - 462
[6] RANDOMIZED OPEN CROSSOVER TRIAL BETWEEN METOCLOPRAMIDE (MCP) AND DEXAMETHAZONE (DXM) FOR THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING
COGNETTI, F
PINNARO, P
CARLINI, P
CONTI, EM
CORTESE, M
POLLERA, CF
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (02): : 183 - 187
[7] DAVID M, 1984, CANCER TREAT REP, V68, P921
[8] ELLERTON J, 1983, P AM SOC CLIN ONCO C, V328, P84
[9] FETTING JH, 1982, CANCER TREAT REP, V66, P1487
[10] LEE BJ, 1981, NEW ENGL J MED, V304, P486